TRX2

TRX2
Launch year 2011
Company Oxford BioLabs
Availability Available
Website trx2.com
Notes
Dietary supplement

TRX2 is a dietary supplement marketed for individuals with hair loss. It is manufactured and sold by Oxford BioLabs in the United Kingdom,[1][2][3] marketed in 2011.

Etymology

The name TRX2 is derived from the Ancient Greek word trichos, meaning hair and the number 2 stands for second generation.[4]

Formulation

TRX2 contains amino acids and vitamins. Its ingredients are L-carnitine, L-tartaric acid, potassium chloride, L-leucine, isoleucine, valine, nicotinic acid, and biotin.[5]

Product description

The product is a dietary supplement, not a drug, and hence it doesn't need to be approved by the U.S. Food and Drug Administration (FDA).[3][6]

Controversy

In January 2014 the UK Advertising Standards Authority upheld a complaint against TRX2 and Oxford Biolabs, citing that advertisements that the company had run for TRX2 were misleading and in breach of EU advertising codes. The company agreed and changed their advertising in line with the code of conduct.[7]

See also

References

  1. ↑ Tyler, Richard (9 January 2011). "Thomas Whitfield's German roots help hair loss product launch". The Daily Telegraph. Retrieved 23 July 2012.
  2. ↑ Tyler, Richard (16 January 2009). "Thomas Whitfield: The Oxford student who plans to make baldness a thing of the past". The Daily Telegraph. Retrieved 23 July 2012.
  3. 1 2 Edwards, Jim (12 January 2011). "Pharma's 4 Best Shots at a Cure for Baldness" (Web). CBSNews.com. CBS News. Retrieved 1 August 2012. it's actually just another dietary supplement and as such doesn't need to be approved by the FDA.
  4. ↑ "Oxford BioLabs". Oxford BioLabs. Retrieved 26 July 2012.
  5. ↑ "Carnipure" (Web). Lonza. Retrieved October 22, 2012.
  6. ↑ "Minoxidil Alternatives" (Web). MPB Research. Retrieved 1 August 2012.
  7. ↑ "ASA Adjudication on Oxford Biolabs Ltd" (Web). Advertising Standards Authority. Retrieved 7 October 2014.
This article is issued from Wikipedia - version of the 6/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.